Telomere Shortening and Associated Chromosomal Instability in Peripheral Blood Lymphocytes of Patients With Hodgkin's Lymphoma Prior to Any Treatment Are Predictive of Second Cancers

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 2, 2007, Pages 465-471

  M'kacher, Radhia ^a   Bennaceur Griscelli, Annelise ^a   Girinsky, Theodore ^a   Koscielny, Serge ^a   Delhommeau, François ^a,b   Dossou, Julien ^a   Violot, Dominique ^a   Leclercq, Evelyne ^a   Courtier, Marie Hélène ^a   Béron Gaillard, Nadine ^a   Assaf, Elias ^a   Ribrag, Vincent ^a   Bourhis, Jean ^a   Feneux, Daniele ^c   Bernheim, Alain ^a   Parmentier, Claude ^a   Carde, Patrice ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c BICÊTRE HOSPITAL   (France)

Author keywords

Chromosomal instability; Hodgkin lymphoma; Second cancer; Telomere shortening

Indexed keywords

CHROMOSOMES; DNA SEQUENCES; HEALTH RISKS; ONCOLOGY; PATHOLOGY; TUMORS;

CHROMOSOMAL INSTABILITY; DNA REPAIR PATHWAYS; HODGKIN LYMPHOMA; LYMPHOCYTES; TELOMERE LENGTH;

BLOOD;

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD DONOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER SURVIVOR; CANCER THERAPY; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DNA REPAIR; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC LINKAGE; HODGKIN DISEASE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOSENSITIVITY; SECOND CANCER; TELOMERE;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, BASAL CELL; CHROMOSOMAL INSTABILITY; COHORT STUDIES; DNA REPAIR; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROSPECTIVE STUDIES; RADIATION TOLERANCE; SKIN NEOPLASMS; SURVIVORS; TELOMERE;

EID: 34247899188     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.01.050     Document Type: Article

References (31)

1. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. (Review). Nat Rev Genet 6 (2005) 611-622
2. Shin J.S., Hong A., Solomon M.J., and Lee C.S. The role of telomeres and telomerase in the pathology of human cancer and aging. Pathology 38 (2006) 103-113
3. Cawthon R.M., Smith K.R., O'Brien E., Sivatchenko A., and Kerber R.A. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361 (2003) 393-395
4. Espejel S., Martin M., Klatt P., et al. Shorter telomeres, accelerated aging and increased lymphoma in DNA-PKcs-deficient mice. EMBO Rep 5 (2004) 503-509
5. Carde P. The chemotherapy/radiation balance in advanced Hodgkin's lymphoma: Overweight which side?. J Clin Oncol 23 (2005) 9058-9062
6. Dores G.M., Metayer C., Curtis R.E., et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years. J Clin Oncol 20 (2002) 3484-3494
7. Rahu K., Auvinen A., Tekkel M., et al. Cancer risk among Chernobyl cleanup workers in Estonia and Latvia, 1986-1998. Int J Cancer 119 (2006) 162-168
8. Hahn W.C., and Weinberg R.A. Rules for making human tumor cells. N Engl J Med 347 (2002) 1593-1603
9. Koontz B.F., Kirkpatrick J.P., Clough R.W., et al. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: Cure balanced against complications. J Clin Oncol 24 (2006) 605-611
10. Tullgren O., Grimfors G., Holm G., et al. Lymphocyte abnormalities predicting a poor prognosis in Hodgkin's disease. A long-term follow-up. Cancer 68 (1991) 768-775
11. Strom S.S., Gu Y., Sigurdson A.J., et al. Chromosome breaks and sister chromatide exchange as predictors of second cancers in Hodgkin's disease. Leuk Lymphoma 28 (1998) 561-566
12. M'kacher R., Girinsky T., Koscielny S., et al. Baseline and treatment-induced chromosomal abnormalities in peripheral blood lymphocytes of Hodgkin's lymphoma patients. Int J Radiat Oncol Biol Phys 57 (2003) 321-326
13. Delhommeau F., Thierry A., Feneux D., et al. Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant. Oncogene 21 (2002) 8262-8271
14. Baird D.M., and Kipling D. The extent and significance of telomere loss with age. (Review). Ann N Y Acad Sci 1019 (2004) 265-268
15. Lee J.J., Nam C.E., Kook H., et al. Constitution and telomere dynamics of bone marrow stromal cells in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 32 (2003) 947-952
16. Ohyashiki J.H., Sashida G., Tauchi T., et al. Telomeres and telomerase in hematologic neoplasia. Oncogene 21 (2002) 680-687
17. Engelhardt M., Mackenzie K., Drullinsky P., et al. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture. Cancer Res 60 (2000) 610-617
18. Wong K.K., Chang S., Weiler S.R., et al. Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat Genet 26 (2000) 85-88
19. Goytisolo F.A., Samper E., Martin-Caballero J., et al. Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J Exp Med 192 (2000) 1625-1636
20. Latre L., Tusell L., Martin M., et al. Shortened telomeres join to DNA breaks interfering with their correct repair. Exp Cell Res 287 (2003) 282-288
21. Bakkenist C.J., and Kastan M.B. Initiating cellular stress responses. (Review). Cell 118 (2004) 9-17
22. Epel E.S., Blackburn E.H., Lin J., et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A 101 (2004) 17312-17315
23. Ben-Porath I., and Weinberg R.A. When cells get stressed: An integrative view of cellular senescence. J Clin Invest 113 (2004) 8-13
24. Dagarag M., Evazyan T., Rao N., et al. Genetic manipulation of telomerase in HIV-specific CD8+ T cells: enhanced antiviral functions accompany the increased proliferative potential and telomere length stabilization. J Immunol 173 (2004) 6303-6311
25. Wu X., Amos C.I., Zhu Y., et al. Telomere dysfunction: A potential cancer predisposition factor. J Natl Cancer Inst 95 (2003) 1211-1218
26. Zhai G., Aviv A., Hunter D.J., et al. Reduction of leucocyte telomere length in radiographic hand osteoarthritis: A population-based study. Ann Rheum Dis 65 (2006) 1444-1448
27. Cozen W., Gill P.S., Ingles S.A., et al. IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood 103 (2004) 3216-3221
28. Biggar R.J., Jaffe E.S., Goedert J.J., et al. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 108 (2006) 3786-3791
29. Jarrett R.F., Stark G.L., White J., et al., Scotland and Newcastle Epidemiology of Hodgkin Disease Study Group. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: A population-based study. Blood 106 (2005) 2444-2451
30. Ding L., Li L.L., Yang J., et al. Epstein-Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-kappaB p65 in human nasopharyngeal carcinoma cells. Int J Biochem Cell Biol 37 (2005) 1881-1889
31. Besson C., Amiel C., Le-Pendeven C., et al. Positive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relatives. J Clin Microbiol 44 (2006) 47-50